Immunovant Chief Medical Officer William Macias receives $6.8M in 2022
Immunovant reports 2022 executive compensation
By ExecPay News
Published: June 30, 2022
Immunovant reported fiscal year 2022 executive compensation information on June 30, 2022.
In 2022, three Immunovant executives received on average a compensation package of $5.7M, a 63% decrease compared to previous year.
Average pay of disclosed executives at Immunovant
William L. Macias, Chief Medical Officer, received $6.8M in total.
Peter Salzmann, Chief Executive Officer, received a compensation package of $5.9M, which decreased by 62% compared to previous year. 68% of the compensation package, or $4M, was in stock awards.
Eva Renee Barnett, Chief Financial Officer, earned $4.4M in 2022.
Immunovant's fiscal year ends on March 31.
Related executives
You may also like
Source: SEC filing on June 30, 2022.